This topic contains a solution. Click here to go to the answer

Author Question: An advantage of using an integrated substance abuse and mental health approach when treating clients ... (Read 71 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
An advantage of using an integrated substance abuse and mental health approach when treating clients with co-occurring disorders is
 
  A. it significantly lowers rate of relapse.
  B. individualized planning and personalization of services.
  C. it increases the availability of treatment funding.
  D. clients can address concerns quickly.

Question 2

Which of the following would NOT be considered a form of harm reduction?
 
  A. A detoxification program as part of a treatment program
  B. A needle exchange program at a homeless shelter
  C. Availability of free condoms at a halfway house
  D. Free taxi service on New Year's eve sponsored by MADD



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cam1229

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

B

Answer to Question 2

A




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jul 31, 2018
Excellent


Dinolord

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library